Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

RxSight (RXST) Gross Profit (2020 - 2025)

Historic Gross Profit for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to $24.2 million.

  • RxSight's Gross Profit fell 393.74% to $24.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $106.5 million, marking a year-over-year increase of 2132.47%. This contributed to the annual value of $98.9 million for FY2024, which is 8402.86% up from last year.
  • Per RxSight's latest filing, its Gross Profit stood at $24.2 million for Q3 2025, which was down 393.74% from $25.2 million recorded in Q2 2025.
  • RxSight's Gross Profit's 5-year high stood at $28.8 million during Q4 2024, with a 5-year trough of -$812000.0 in Q2 2021.
  • For the 5-year period, RxSight's Gross Profit averaged around $13.5 million, with its median value being $12.0 million (2023).
  • As far as peak fluctuations go, RxSight's Gross Profit plummeted by 7130.8% in 2021, and later skyrocketed by 68965.52% in 2022.
  • RxSight's Gross Profit (Quarter) stood at $2.9 million in 2021, then surged by 158.7% to $7.4 million in 2022, then skyrocketed by 137.86% to $17.7 million in 2023, then surged by 63.07% to $28.8 million in 2024, then dropped by 15.84% to $24.2 million in 2025.
  • Its Gross Profit was $24.2 million in Q3 2025, compared to $25.2 million in Q2 2025 and $28.3 million in Q1 2025.